Public Health · Research

HIV Drug Resistance reports

Coverage across 10 countries and regions. Each report follows the same 16 sections, with sources and data gaps named.

Get the full HIV Drug Resistance public health report

The full report covers burden, affected groups, risk factors, screening, treatment coverage, programmes, gaps and outlook, with a source and year for every figure.

Buy the full report Request free sample
HIV Drug Resistance reports by place
PlaceActive trialsReport
World19View report
Africa10View report
Kenya2View report
Malawi0View report
Mozambique3View report
Nigeria0View report
South Africa7View report
Tanzania2View report
Uganda1View report
Zambia0View report

Public clinical research

19 active trials found worldwide on ClinicalTrials.gov.

See the public search

Latest public research

  1. Lenacapavir in the Treatment and Prevention of HIV-1 Infection: A Narrative Review of Clinical Efficacy and Resistance Selection Risk.Cureus, 2026
  2. A narrative review of HIV surveillance strategies used in selected sub-Saharan African countries.Frontiers in public health, 2026
  3. Pretreatment HIV-1 drug resistance, genetic diversity, and molecular transmission networks among individuals initiating antiretroviral therapy in Luzhou, China.BMC infectious diseases, 2026
  4. Molecular Transmission Clustering and Pretreatment Drug Resistance Among Men Infected With HIV-1 Who Have Sex With Men in Baotou, China: A Cross-Sectional Subgroup Analysis.JMIR public health and surveillance, 2026
  5. Low-level viraemia and other factors associated with virologic outcomes among children living with HIV on antiretroviral therapy in Kenya, 2017-2023: a retrospective longitudinal analysis.The Lancet regional health. Africa, 2026

Public trial and paper counts come from ClinicalTrials.gov and PubMed. Acuitas market figures are not published on this page.